Global Malaria Programme (GMP)


The Global malaria Programme (GMP) is part of the WHO, the foremost global authority on health.

GMP is responsible for malaria surveillance, monitoring and evaluation, policy and strategy formulation, technical assistance, and coordination of WHO's global efforts to fight malaria.

:: MONITORING & EVALUATION

Helping stardardize and systematize data collection.

:: CASE MANAGEMENT

Supporting research and issuing guidance.

:: VECTOR CONTROL

Scaling up malaria control and prevention through ITNs, IRS & IVM.

:: RESEARCH

Boosting quality and reducing costs.








































WHAT'S NEW

Report of the Technical Expert Group (TEG)
April 2009, Geneva

Meeting which reviewed the evidence on Intermittent Preventive Therapy in Infancy (IPTi) with Sulfadoxine-Pyrimethamine (SP).

MALVAC 2008 Meeting: Measures of Malaria Vaccine Efficacy – Scientific,
Regulatory and Public Health Perspectives

An increasing number of malaria vaccine candidates have entered Phase 1 trials and some have progressed to field efficacy trials in populations where malaria is endemic. A pivotal phase 3 trial of the most advanced candidate is scheduled for 2009-2011.

Global Malaria Control and Elimination
report of a technical review
Outcomes of a meeting on Global malaria control and elimination  PDF PDF version


HOT TOPICS

Malaria and travellers
Malaria endemic countries

LATEST PUBLICATIONS

World Malaria Report 2008 Half of the world's population is at risk of malaria,

and an estimated 247 million cases led to nearly 881 000 deaths in 2006. The World malaria report 2008 describes the global distribution of cases and deaths, how WHO-recommended control strategies have been adopted and implemented in endemic countries, sources of funding for malaria control, and recent evidence that prevention and treatment can alleviate the burden of disease. PDF PDF version

ISBN978 92 4 156369 7

Global malaria control and elimination: report of a meeting on containment of artemisinin tolerance

Early signs of artemisinins becoming less effective againt P.falciparum malaria are now evident at the Thai-Cambodian border. This report presents the outline of a containment plan to avert potentially grave consequences of artemisinin-tolerant parasites from spreading further, as which happened with chloroquine and sulfadoxine-pyrimethamine. PDF PDF version

ISBN 978 92 4 159681 7


/* */